2022-02-282023-02-282023-02-28false13944670A&O MEDICAL LTD2023-11-06iso4217:GBPxbrli:pure139446702022-02-28139446702023-02-28139446702022-02-282023-02-28139446702022-02-27139446702022-02-27139446702022-02-272022-02-2713944670bus:SmallEntities2022-02-282023-02-2813944670bus:AuditExempt-NoAccountantsReport2022-02-282023-02-2813944670bus:AbridgedAccounts2022-02-282023-02-2813944670bus:PrivateLimitedCompanyLtd2022-02-282023-02-2813944670core:WithinOneYear2023-02-2813944670core:AfterOneYear2023-02-2813944670core:WithinOneYear2022-02-2713944670core:AfterOneYear2022-02-2713944670core:ShareCapital2023-02-2813944670core:SharePremium2023-02-2813944670core:RevaluationReserve2023-02-2813944670core:OtherReservesSubtotal2023-02-2813944670core:RetainedEarningsAccumulatedLosses2023-02-2813944670core:ShareCapital2022-02-2713944670core:SharePremium2022-02-2713944670core:RevaluationReserve2022-02-2713944670core:OtherReservesSubtotal2022-02-2713944670core:RetainedEarningsAccumulatedLosses2022-02-2713944670core:LandBuildings2023-02-2813944670core:PlantMachinery2023-02-2813944670core:Vehicles2023-02-2813944670core:FurnitureFittings2023-02-2813944670core:OfficeEquipment2023-02-2813944670core:NetGoodwill2023-02-2813944670core:IntangibleAssetsOtherThanGoodwill2023-02-2813944670core:ListedExchangeTraded2023-02-2813944670core:UnlistedNon-exchangeTraded2023-02-2813944670core:LandBuildings2022-02-2713944670core:PlantMachinery2022-02-2713944670core:Vehicles2022-02-2713944670core:FurnitureFittings2022-02-2713944670core:OfficeEquipment2022-02-2713944670core:NetGoodwill2022-02-2713944670core:IntangibleAssetsOtherThanGoodwill2022-02-2713944670core:ListedExchangeTraded2022-02-2713944670core:UnlistedNon-exchangeTraded2022-02-2713944670core:LandBuildings2022-02-282023-02-2813944670core:PlantMachinery2022-02-282023-02-2813944670core:Vehicles2022-02-282023-02-2813944670core:FurnitureFittings2022-02-282023-02-2813944670core:OfficeEquipment2022-02-282023-02-2813944670core:NetGoodwill2022-02-282023-02-2813944670core:IntangibleAssetsOtherThanGoodwill2022-02-282023-02-2813944670core:ListedExchangeTraded2022-02-282023-02-2813944670core:UnlistedNon-exchangeTraded2022-02-282023-02-2813944670core:MoreThanFiveYears2022-02-282023-02-2813944670core:Non-currentFinancialInstruments2023-02-2813944670core:Non-currentFinancialInstruments2022-02-2713944670dpl:CostSales2022-02-282023-02-2813944670dpl:DistributionCosts2022-02-282023-02-2813944670core:LandBuildings2022-02-282023-02-2813944670core:PlantMachinery2022-02-282023-02-2813944670core:Vehicles2022-02-282023-02-2813944670core:FurnitureFittings2022-02-282023-02-2813944670core:OfficeEquipment2022-02-282023-02-2813944670dpl:AdministrativeExpenses2022-02-282023-02-2813944670core:NetGoodwill2022-02-282023-02-2813944670core:IntangibleAssetsOtherThanGoodwill2022-02-282023-02-2813944670dpl:GroupUndertakings2022-02-282023-02-2813944670dpl:ParticipatingInterests2022-02-282023-02-2813944670dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-282023-02-2813944670core:ListedExchangeTraded2022-02-282023-02-2813944670dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-282023-02-2813944670core:UnlistedNon-exchangeTraded2022-02-282023-02-2813944670dpl:CostSales2022-02-272022-02-2713944670dpl:DistributionCosts2022-02-272022-02-2713944670core:LandBuildings2022-02-272022-02-2713944670core:PlantMachinery2022-02-272022-02-2713944670core:Vehicles2022-02-272022-02-2713944670core:FurnitureFittings2022-02-272022-02-2713944670core:OfficeEquipment2022-02-272022-02-2713944670dpl:AdministrativeExpenses2022-02-272022-02-2713944670core:NetGoodwill2022-02-272022-02-2713944670core:IntangibleAssetsOtherThanGoodwill2022-02-272022-02-2713944670dpl:GroupUndertakings2022-02-272022-02-2713944670dpl:ParticipatingInterests2022-02-272022-02-2713944670dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-272022-02-2713944670core:ListedExchangeTraded2022-02-272022-02-2713944670dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-272022-02-2713944670core:UnlistedNon-exchangeTraded2022-02-272022-02-2713944670core:NetGoodwill2023-02-2813944670core:IntangibleAssetsOtherThanGoodwill2023-02-2813944670core:LandBuildings2023-02-2813944670core:PlantMachinery2023-02-2813944670core:Vehicles2023-02-2813944670core:FurnitureFittings2023-02-2813944670core:OfficeEquipment2023-02-2813944670core:AfterOneYear2023-02-2813944670core:WithinOneYear2023-02-2813944670core:ListedExchangeTraded2023-02-2813944670core:UnlistedNon-exchangeTraded2023-02-2813944670core:ShareCapital2023-02-2813944670core:SharePremium2023-02-2813944670core:RevaluationReserve2023-02-2813944670core:OtherReservesSubtotal2023-02-2813944670core:RetainedEarningsAccumulatedLosses2023-02-2813944670core:NetGoodwill2022-02-2713944670core:IntangibleAssetsOtherThanGoodwill2022-02-2713944670core:LandBuildings2022-02-2713944670core:PlantMachinery2022-02-2713944670core:Vehicles2022-02-2713944670core:FurnitureFittings2022-02-2713944670core:OfficeEquipment2022-02-2713944670core:AfterOneYear2022-02-2713944670core:WithinOneYear2022-02-2713944670core:ListedExchangeTraded2022-02-2713944670core:UnlistedNon-exchangeTraded2022-02-2713944670core:ShareCapital2022-02-2713944670core:SharePremium2022-02-2713944670core:RevaluationReserve2022-02-2713944670core:OtherReservesSubtotal2022-02-2713944670core:RetainedEarningsAccumulatedLosses2022-02-2713944670core:NetGoodwill2022-02-2713944670core:IntangibleAssetsOtherThanGoodwill2022-02-2713944670core:LandBuildings2022-02-2713944670core:PlantMachinery2022-02-2713944670core:Vehicles2022-02-2713944670core:FurnitureFittings2022-02-2713944670core:OfficeEquipment2022-02-2713944670core:AfterOneYear2022-02-2713944670core:WithinOneYear2022-02-2713944670core:ListedExchangeTraded2022-02-2713944670core:UnlistedNon-exchangeTraded2022-02-2713944670core:ShareCapital2022-02-2713944670core:SharePremium2022-02-2713944670core:RevaluationReserve2022-02-2713944670core:OtherReservesSubtotal2022-02-2713944670core:RetainedEarningsAccumulatedLosses2022-02-2713944670core:AfterOneYear2022-02-282023-02-2813944670core:WithinOneYear2022-02-282023-02-2813944670core:Non-currentFinancialInstrumentscore:CostValuation2022-02-282023-02-2813944670core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-02-282023-02-2813944670core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-02-282023-02-2813944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-02-282023-02-2813944670core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-02-282023-02-2813944670core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-02-282023-02-2813944670core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-02-282023-02-2813944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-02-282023-02-2813944670core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-02-282023-02-2813944670core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2813944670core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:CostValuation2022-02-2713944670core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-02-2713944670core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-02-2713944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-02-2713944670core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-02-2713944670core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-02-2713944670core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-02-2713944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-02-2713944670core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-02-2713944670bus:Director12022-02-282023-02-28

A&O MEDICAL LTD

Registered Number
13944670
(England and Wales)

Unaudited Financial Statements for the Period ended
28 February 2023

A&O MEDICAL LTD
Company Information
for the period from 28 February 2022 to 28 February 2023

Director

OBAIDULLAH WAHEED

Company Secretary

ASADULLAH ZIA RAJPUT

Registered Address

Hamilton House
4a The Avenue
London
E4 9LD

Registered Number

13944670 (England and Wales)
A&O MEDICAL LTD
Balance Sheet as at
28 February 2023

Notes

2023

£

£

Fixed assets
Tangible assets61,622
1,622
Current assets
Stocks7175
Cash at bank and on hand2,288
2,463
Creditors amounts falling due within one year8(4,755)
Net current assets (liabilities)(2,292)
Total assets less current liabilities(670)
Net assets(670)
Capital and reserves
Called up share capital100
Profit and loss account(770)
Shareholders' funds(670)
The financial statements were approved and authorised for issue by the Director on 6 November 2023, and are signed on its behalf by:
OBAIDULLAH WAHEED
Director
Registered Company No. 13944670
A&O MEDICAL LTD
Notes to the Financial Statements
for the period ended 28 February 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The company's principal activity during the year was that of Cosmetic surgery.
4.Accounting policies
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
Stocks policy
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
5.Employee information

2023
Average number of employees during the year2
6.Property, plant and equipment

Total

£
Cost or valuation
Additions2,163
At 28 February 232,163
Depreciation and impairment
Charge for year541
At 28 February 23541
Net book value
At 28 February 231,622
At 27 February 22-
7.Stocks
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).

2023

£
Finished goods175
Total175
8.Creditors within one year

2023

£
Other creditors2,755
Accrued liabilities and deferred income2,000
Total4,755
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.